EMBO Molecular Medicine
@embomolmed.org did:plc:2gdibo6rzq76w63uvxtonntd
OpenAccess journal dedicated to high quality research at the interface between clinical & basic science. Tweets from journal editors
Bei Bluesky seit
- Follower
- 432
- Folgt
- 206
- Posts
- 246
- Tage in Ranglisten
- 0
Zusammenfassung
EMBO Molecular Medicine (@embomolmed.org) ist seit 5 Dezember 2024 auf Bluesky. Das Konto hat 432 Follower, folgt 206 Konten und hat 246 Posts veröffentlicht.
Ranglisten-Platzierungen
Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.
Dieses Konto war noch in keiner Tagesrangliste.
Zuletzt gelikte Posts
Öffentliche Likes aus dem Bluesky-Netzwerk.
Good Sunday, all. There is a wonderful curated selection of papers in #cancermetabolism and #mitochondrialbiology here: biomed.news/bims-camemi/... @biomednews.bsky.social #keepreading The real truth, that dare not speak itself, is that no one is in control. Absolutely no one. Terence McKenna
Post anzeigenSo happy that it’s finally out.
Post anzeigenExcited to share our new study showing how rhabdomyosarcoma cells respond differently to the inhibition of cholesterol synthesis compared to healthy myoblasts. Great work by a recent PhD Nebeyu Gizaw🎓 #UniHelsinki @wrihelsinki.bsky.social #UniJyvaskyla
Post anzeigenAlso, huge thanks to the referees and editorial team over at @embomolmed.org! Professional handling, open dialogue and sound peer review process 💯
Post anzeigenSpecial thanks to the @embomolmed.org editors and Dr Roth and the peer-reviewers for the constructive feedback! It was a very nice, straightforward and constructive publishing experience :) Lastly, do not hesitate to reach out for any feedback or plans to collaborate on this work to us!
Post anzeigen
Blockierte Konten
Blockierungen sind auf Bluesky öffentlich.
Dieses Konto blockiert niemanden.